Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$1.07 -0.05 (-4.46%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.06 -0.02 (-1.40%)
As of 07/25/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RMTI vs. ARAY, RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, and IDXX

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include Accuray (ARAY), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), and IDEXX Laboratories (IDXX). These companies are all part of the "health care equipment" industry.

Rockwell Medical vs. Its Competitors

Accuray (NASDAQ:ARAY) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

64.1% of Accuray shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 3.6% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Rockwell Medical has lower revenue, but higher earnings than Accuray.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accuray$446.55M0.31-$15.55MN/AN/A
Rockwell Medical$101.49M0.36-$480KN/AN/A

Rockwell Medical has a consensus price target of $4.00, suggesting a potential upside of 273.83%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Accuray.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Rockwell Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Accuray has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.

In the previous week, Accuray had 1 more articles in the media than Rockwell Medical. MarketBeat recorded 2 mentions for Accuray and 1 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.89 beat Accuray's score of 1.77 indicating that Rockwell Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Accuray Very Positive
Rockwell Medical Very Positive

Accuray has a net margin of 0.14% compared to Rockwell Medical's net margin of -0.27%. Accuray's return on equity of 1.43% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Accuray0.14% 1.43% 0.14%
Rockwell Medical -0.27%-0.90%-0.47%

Summary

Rockwell Medical beats Accuray on 8 of the 15 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$38.28M$10.55B$5.70B$9.50B
Dividend YieldN/A2.00%4.58%4.01%
P/E RatioN/A17.0728.1020.05
Price / Sales0.3629.17429.0189.19
Price / Cash8.8623.0336.2258.56
Price / Book1.063.698.665.87
Net Income-$480K$234.77M$3.25B$258.55M
7 Day Performance-2.73%6.32%4.22%3.73%
1 Month Performance32.26%7.94%10.51%11.75%
1 Year Performance-43.39%-13.57%34.40%18.03%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
3.9965 of 5 stars
$1.07
-4.5%
$4.00
+273.8%
-42.2%$38.28M$101.49M0.00300Positive News
ARAY
Accuray
3.1256 of 5 stars
$1.36
flat
N/A-27.3%$140.10M$465.25M0.001,040News Coverage
Positive News
RSLS
ReShape Lifesciences
0.4256 of 5 stars
$2.39
+0.4%
N/A-99.2%$5.71M$8.01M-0.0150Positive News
ABT
Abbott Laboratories
4.9902 of 5 stars
$132.05
+0.0%
$143.11
+8.4%
+19.4%$229.74B$42.34B17.13114,000
ISRG
Intuitive Surgical
4.7034 of 5 stars
$516.44
+0.9%
$592.86
+14.8%
+13.5%$185.10B$8.35B75.7215,638Trending News
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision
BSX
Boston Scientific
4.6348 of 5 stars
$104.39
+1.1%
$116.09
+11.2%
+42.8%$154.43B$16.75B76.1953,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
SYK
Stryker
4.5365 of 5 stars
$391.46
+0.5%
$428.55
+9.5%
+23.2%$149.41B$22.60B52.9053,000Positive News
Upcoming Earnings
MDT
Medtronic
4.6569 of 5 stars
$89.73
-0.2%
$97.47
+8.6%
+18.5%$115.08B$33.54B24.7995,000Positive News
BDX
Becton, Dickinson and Company
4.8276 of 5 stars
$177.15
+0.7%
$219.22
+23.7%
-20.3%$50.77B$20.87B33.8174,000Positive News
Dividend Announcement
Insider Trade
High Trading Volume
EW
Edwards Lifesciences
4.3573 of 5 stars
$78.35
+0.4%
$80.40
+2.6%
+33.9%$45.96B$5.44B11.1915,800Trending News
Earnings Report
Analyst Forecast
Gap Up
IDXX
IDEXX Laboratories
3.5802 of 5 stars
$531.42
-0.4%
$558.11
+5.0%
+20.1%$42.74B$3.93B49.1111,000Positive News

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners